Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement

  • Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs
  • The transaction values the combined company at an enterprise value of approximately $1.1 billion and is expected to provide more than $425 million in cash on the balance sheet after closing including a fully committed $115 million PIPE, priced at $10.00 per share
  • PIPE participants include strategic investor, BD (Becton, Dickinson and Company) (NYSE: BDX) - one of the largest global medical technology companies in the world - new institutional investors and existing investors including Bill Gates, Vinod Khosla’s Khosla Ventures, Eric Schmidt's Innovation Endeavors, and Philip Liang’s E15 VC.
  • An investor conference call to discuss the proposed transaction will be conducted today, April 15, 2021, at 8:00 AM ET


D8 Holdings Corp. is a recently formed company whose business purpose is merger and acquisitions in the consumer sector. Our objective is to identify a target business that is under-valued relative to its potential and ready for transformative improvement. We will leverage our founders’ unique operational expertise to create a new growth trajectory for a target company and deliver shareholder value.